OKAY
833230
CHANGFU CO.,LTD
871396
Gansu Longshenrongfa Pharmaceutical Industry
300534
4
Tibet Duo Rui Pharmaceutical
301075
5
Chengda Pharmaceuticals
301201
CN Stock MarketDetailed Quotes
603518 Jinhong Fashion Group
- 9.20
- +0.26+2.91%
Not Open Apr 1 15:00 CST
3.20BMarket Cap10.44P/E (TTM)
9.23High8.90Low107.25KlotVolume8.98Open8.94Pre Close97.91MTurnover3.11%Turnover Ratio10.44P/E (Static)347.45MShares11.0052wk High0.89P/B3.17BFloat Cap6.0152wk Low9.83Limit Up344.81MShs Float32.27Historical High8.05Limit Down3.69%Amplitude3.79Historical Low0.26Dividend TTM9.13Avg Price46.28KlotAsk2.83%Div YieldTTM100Lot Size60.54KlotBid
Jinhong Fashion Group Key Stats
All
YOY
| (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q3)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q3)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q9)Sep 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total operating revenue | -3.29%4.4B | -5.61%2.92B | -1.59%2.08B | -1.24%1.15B | 16.55%4.54B | 14.39%3.1B | 14.33%2.11B | 8.05%1.17B | -9.83%3.9B | -3.97%2.71B |
| Operating revenue | -3.29%4.4B | -5.61%2.92B | -1.59%2.08B | -1.24%1.15B | 16.55%4.54B | 14.39%3.1B | 14.33%2.11B | 8.05%1.17B | -9.83%3.9B | -3.97%2.71B |
| Other operating revenue | ---- | ---- | 41.65%15.93M | ---- | ---- | ---- | 51.38%11.25M | ---- | 16.60%14.75M | ---- |
| Total operating cost | -2.98%4.02B | -4.62%2.73B | -1.30%1.9B | -2.26%1B | 6.83%4.14B | 5.69%2.86B | 5.75%1.92B | 0.24%1.03B | -3.91%3.88B | 2.77%2.71B |
| Operating cost | -1.52%1.38B | -5.78%898.43M | -3.03%635.36M | -3.87%343.58M | 16.57%1.4B | 15.40%953.59M | 15.74%655.22M | 7.21%357.4M | -8.58%1.2B | -0.69%826.36M |
| Operating tax surcharges | -7.71%25.76M | -12.73%20.14M | 3.42%14.75M | -3.50%8.97M | 20.12%27.92M | 18.35%23.08M | 12.99%14.26M | 20.99%9.3M | -5.42%23.24M | 7.15%19.5M |
| Operating expense | -4.32%2.23B | -4.46%1.52B | -1.17%1.05B | -2.36%549.54M | 3.77%2.33B | 2.57%1.59B | 2.87%1.06B | -1.08%562.84M | 0.77%2.25B | 8.00%1.55B |
| Administration expense | 7.38%190.23M | 11.24%147.67M | 23.56%101.11M | 28.93%51.59M | 14.14%177.16M | 15.43%132.74M | 15.97%81.83M | -3.75%40.02M | -4.68%155.21M | 1.77%114.99M |
| Financial expense | -26.86%67.56M | -39.84%46.13M | -40.46%33.4M | -42.47%16.49M | -41.84%92.37M | -37.93%76.68M | -39.57%56.09M | -40.03%28.67M | -29.37%158.81M | -27.36%123.53M |
| -Interest expense (Financial expense) | -27.86%72.04M | -37.01%49.83M | -36.85%36.65M | -39.14%17.97M | -38.07%99.86M | -37.11%79.1M | -38.45%58.04M | -39.30%29.52M | -28.69%161.25M | -26.73%125.77M |
| -Interest Income (Financial expense) | 37.89%-6.07M | -25.25%-4.84M | -33.14%-3.97M | -47.10%-1.88M | -132.53%-9.77M | -28.70%-3.86M | -45.50%-2.98M | -32.72%-1.28M | -26.62%-4.2M | -13.64%-3M |
| Research and development | 11.04%125.43M | 14.56%97.29M | 18.61%65.11M | 17.59%32.44M | 22.48%112.96M | 17.51%84.92M | 21.28%54.9M | 15.07%27.59M | 16.04%92.23M | 10.60%72.27M |
| Credit Impairment Loss | 9.21%-16.33M | -25.52%-11.45M | 33.80%-5.21M | 110.91%765.02K | -241.73%-17.98M | -379.48%-9.12M | -859.61%-7.87M | -660.74%-7.01M | 43.82%-5.26M | -3.55%3.26M |
| Asset Impairment Loss | 134.33%5.87M | 90.64%6.24M | 158.57%8.38M | 2.64%4.43M | -3.48%-17.1M | 53.42%3.27M | 195.98%3.24M | 308.10%4.32M | -1,035.02%-16.53M | 114.11%2.13M |
| Other net revenue | 1,229.11%26.12M | 450.96%20.12M | 414.24%14.16M | 321.16%5.67M | 82.70%-2.31M | -199.30%-5.73M | -101.62%-4.51M | -202.34%-2.57M | -227.45%-13.37M | 187.31%5.77M |
| Invest income | 99.17%-16.44K | ---- | ---- | ---- | -187.35%-1.98M | ---- | ---- | ---- | ---690.49K | ---167.82K |
| Asset deal income | 65.46%-687.75K | -963.75%-1.82M | -148.55%-412.58K | 105.76%3.33K | -215.19%-1.99M | -2,527.69%-170.63K | -1,259.63%-165.99K | -268.66%-57.87K | 582.30%1.73M | 103.76%7.03K |
| Other revenue | 1.45%37.28M | 9,429.31%27.15M | 3,904.82%11.41M | 151.73%472.78K | 398.01%36.75M | -47.09%284.89K | 10.67%284.87K | -26.92%187.81K | 3.98%7.38M | -89.86%538.45K |
| Operating profit | 0.60%401.18M | -6.74%211.88M | 5.53%192.92M | 12.25%155.9M | 5,568.08%398.78M | 6,368.13%227.2M | 628.82%182.81M | 133.93%138.9M | -97.52%7.04M | -98.00%3.51M |
| Add:Non operating Income | -50.55%2.64M | -91.23%3.15M | -94.40%753.31K | 158.25%1.49M | -81.39%5.34M | 32.22%35.94M | -46.30%13.46M | 64.85%577.84K | -3.93%28.69M | 25.95%27.18M |
| Less:Non operating expense | -39.41%1.03M | 1.60%1.78M | -1.66%1.16M | -18.74%595.94K | -58.10%1.71M | -25.76%1.75M | -19.15%1.18M | -1.28%733.37K | 203.45%4.07M | 136.06%2.36M |
| Total profit | 0.09%402.79M | -18.42%213.26M | -1.32%192.51M | 13.02%156.8M | 1,171.05%402.41M | 822.39%261.4M | 300.68%195.09M | 135.22%138.74M | -89.85%31.66M | -85.58%28.34M |
| Less:Income tax cost | -7.89%96.52M | -27.17%51.62M | -13.50%44.77M | 12.52%40.68M | 363.59%104.79M | 263.21%70.88M | 295.57%51.76M | 102.68%36.15M | -145.17%-39.75M | -177.66%-43.43M |
| Net profit | 2.90%306.26M | -15.16%161.63M | 3.08%147.74M | 13.19%116.12M | 316.76%297.62M | 165.45%190.51M | 302.56%143.33M | 149.32%102.59M | -68.12%71.41M | -48.94%71.77M |
| Net profit from continuing operation | 2.90%306.26M | -15.16%161.63M | 3.08%147.74M | 13.19%116.12M | 316.76%297.62M | 165.45%190.51M | 302.56%143.33M | 149.32%102.59M | -68.12%71.41M | -48.94%71.77M |
| Net profit of parent company owners | 2.90%306.26M | -15.16%161.63M | 3.08%147.74M | 13.19%116.12M | 316.76%297.62M | 165.45%190.51M | 302.56%143.33M | 149.32%102.59M | -68.12%71.41M | -48.94%71.77M |
| Earning per share | ||||||||||
| Basic earning per share | 2.30%0.89 | -16.07%0.47 | 2.38%0.43 | 10.00%0.33 | 248.00%0.87 | 154.55%0.56 | 281.82%0.42 | 114.29%0.3 | -69.88%0.25 | -57.69%0.22 |
| Diluted earning per share | 2.41%0.85 | -16.07%0.47 | 2.38%0.43 | 10.00%0.33 | 232.00%0.83 | 154.55%0.56 | 281.82%0.42 | 130.77%0.3 | -69.14%0.25 | -57.69%0.22 |
| Other composite income | -944.92%-1.67M | 20.31%-538.67K | -108.57%-813.22K | -130.45%-672.71K | -74.19%197.49K | -118.79%-675.98K | -114.68%-389.9K | -115.49%-291.92K | 436.33%765.1K | 132.76%3.6M |
| Other composite income of parent company owners | -944.92%-1.67M | 20.31%-538.67K | -108.57%-813.22K | -130.45%-672.71K | -74.19%197.49K | -118.79%-675.98K | -114.68%-389.9K | -115.49%-291.92K | 436.33%765.1K | 132.76%3.6M |
| Total composite income | 2.27%304.59M | -15.14%161.09M | 2.79%146.93M | 12.86%115.45M | 312.61%297.82M | 151.88%189.84M | 273.59%142.94M | 137.73%102.29M | -67.75%72.18M | -46.96%75.37M |
| Total composite income of parent company owners | 2.27%304.59M | -15.14%161.09M | 2.79%146.93M | 12.86%115.45M | 312.61%297.82M | 151.88%189.84M | 273.59%142.94M | 137.73%102.29M | -67.75%72.18M | -46.96%75.37M |
| Currency Unit | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY | CNY |
| Accounting Standards | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) | CAS (2007) |
| Audit Opinions | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- | -- | -- | Unqualified opinion | -- |
| Auditor | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- | -- | -- | Notarized Tianye Certified Public Accountants Firm (Special General Partnership) | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.